Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
ONGRF$0.37-0.00(-1.22%)ONGold Files NI 43-101 Technical Report for the Monument Bay Gold Project, Manitoba[6:07:00 PM ET]GTE$11.25-0.32(-2.77%)Gran Tierra Energy Inc. Provides Release Date for its 2026 Third Quarter Results[6:05:00 PM ET]KCLI$34.74+0.09(+0.25%)Kansas City Life Announces Appointment of Kellie S. Needham as Director Kansas City Life Insurance Company (the "Company") announces that the Board of Directors has appointed Kellie S. Needham to the Board effective...[5:56:00 PM ET]EPM$3.85-0.04(-1.01%)Evolution Petroleum Schedules Fiscal First Quarter 2027 Earnings Release and Conference Call[5:46:22 PM ET]LODE$1.64-0.07(-4.09%)Comstock Refinances First Three Trophy-Class Office Towers at Reston Station[5:45:00 PM ET]TFC$49.32+0.90(+1.86%)Truist Expands Efforts To Address Homelessness and Housing Instability in Charlotte[5:45:00 PM ET]SIBN$22.41+0.58(+2.66%)SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026[5:43:56 PM ET]AVCNF$0.07+0.00(+4.04%)Avicanna Announces Closing of Non-Brokered Private Placement of Non-Convertible Debenture Units[5:30:00 PM ET]NBMFF$0.060.00(0.00%)NEO Battery Reports Fiscal Year 2027 Second Quarter Results NEO Battery Materials Ltd. ("NEO" or the "Company") (TSXV: NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery manufacturer enabling...[5:30:00 PM ET]DOSEF$0.100.00(0.00%)Doseology Announces Management Cease Trade Order for Late Filing of Annual Audited Financial Statements[5:30:00 PM ET]PII$60.27+1.63(+2.78%)Polaris Declares Regular Cash Dividend Polaris Inc. (NYSE: PII) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.68 per share payable on...[5:29:00 PM ET]ADTN$6.88-0.08(-1.15%)ADTRAN Holdings, Inc. Appoints Dr. Christian H. Terlinde to Board of Directors[5:27:00 PM ET]

TMDX · NASDAQ

TransMedics Group, Inc.

$67.94 +1.10 (+1.65%)

Company overview

TransMedics Group, Inc. is a commercial-stage medical technology company that transforms organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company offers the Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that uses proprietary technology to replicate near-physiologic conditions for donor organs outside the human body. The Organ Care System includes OCS Lung for preserving standard criteria donor lungs for double-lung transplantation, OCS Heart for extracorporeal perfusion and preservation of donor hearts, and OCS Liver for preserving donor livers. Founded in 1998, the company is headquartered in Andover, Massachusetts.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Market cap
$2.4B
Employees
728
Headquarters
Andover, MA
Website
transmedics.com
CEO
Waleed H. Hassanein
Listed
May 2, 2019
P/E
13.51
Dividend yield
0.00%

Company financials

Revenue
$636M
Gross profit
$376M
Operating income
$94.4M
EBITDA
$137M
Net income
$172M
EPS
$5.03
Total assets
$1.4B
Total debt
$819M
Gross margin
59.09%
Net margin
27.04%
Earnings yield
7.40%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No annual geographic segmentation.

Showing FY 2025

Price chart

58.0372.0586.08100.10114.13
TMDX 1D NASDAQ O69.02H69.98L66.68C66.90-2.83 (-4.06%)Vol1.18M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
TMDXTransMedics Group, Inc. Press release TransMedics to Present at Upcoming Investor Conferences TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with... PR Newswire
TMDXTransMedics Group, Inc. Press release TransMedics selects Gogo Galileo HDX for nationwide organ transport fleet GlobeNewswire
TMDXTransMedics Group, Inc. Press release TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026 TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with... PR Newswire
TMDXTransMedics Group, Inc. Stock news A Look at TransMedics Group Inc (TMDX) After 3.1% Decline -- GF Value $160.75 vs Price $72.40 GuruFocus
TMDXTransMedics Group, Inc. Stock news Critical Review: TransMedics Group (NASDAQ:TMDX) & iRhythm Technologies (NASDAQ:IRTC) Defense World
TMDXTransMedics Group, Inc. Stock news TransMedics Group Inc (TMDX) Shares Fall 5.8% -- What GF Score of 74 Tells Investors GuruFocus
TMDXTransMedics Group, Inc. Stock news TransMedics Group (NASDAQ:TMDX) Shares Up 4.5% After Insider Buying Activity Defense World
TMDXTransMedics Group, Inc. Stock news TransMedics Group, Inc. (TMDX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Seeking Alpha
TMDXTransMedics Group, Inc. Legal TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX GuruFocus
TMDXTransMedics Group, Inc. Legal TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX Business Wire
TMDXTransMedics Group, Inc. Press release TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook PR Newswire
TMDXTransMedics Group, Inc. Press release Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire
TMDXTransMedics Group, Inc. Stock news TransMedics Group Inc (TMDX) Shares Surge 3.2% -- What GF Score of 69 Tells Investors GuruFocus
TMDXTransMedics Group, Inc. Stock news Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure? Zacks Investment Research
TMDXTransMedics Group, Inc. Stock news Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report? Zacks Investment Research
TMDXTransMedics Group, Inc. Legal TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX GlobeNewsWire
TMDXTransMedics Group, Inc. Legal Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX GuruFocus
TMDXTransMedics Group, Inc. Legal Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX PRNewsWire
TMDXTransMedics Group, Inc. Press release TransMedics to Present at Upcoming September Investor Conferences PRNewsWire
TMDXTransMedics Group, Inc. Legal TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX GlobeNewsWire
See more
FAQ

Questions about TransMedics Group, Inc.

What does TransMedics Group, Inc. do?
TransMedics Group, Inc. is a commercial-stage medical technology company that transforms organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company offers the Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that uses proprietary technology to replicate near-physiologic conditions for donor organs outside the human body. The Organ Care System includes OCS Lung for preserving standard criteria donor lungs for double-lung transplantation, OCS Heart for extracorporeal perfusion and preservation of donor hearts, and OCS Liver for preserving donor livers. Founded in 1998, the company is headquartered in Andover, Massachusetts.
What is TMDX's market cap?
TransMedics Group, Inc. (TMDX) is a listed stock with a live quote. The latest market cap on this page is $2.4B.
Where is TransMedics Group, Inc. headquartered?
TransMedics Group, Inc. is headquartered in Andover, MA.
How do I get TMDX news from the API?
Call GET /v1/news?tickers=TMDX. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does TMDX news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for TMDX, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the TMDX price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs